Insider Transactions in Q1 2025 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 19
2025
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Open market or private sale
|
Direct |
8,500
-21.68%
|
$714,000
$84.09 P/Share
|
|
Feb 13
2025
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Open market or private sale
|
Direct |
6,000
-19.92%
|
$510,000
$85.34 P/Share
|
|
Feb 08
2025
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Payment of exercise price or tax liability
|
Direct |
6,404
-14.04%
|
$557,148
$87.28 P/Share
|
|
Feb 08
2025
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Exercise of conversion of derivative security
|
Direct |
13,002
+22.18%
|
$1,131,174
$87.28 P/Share
|
|
Feb 06
2025
|
Inge G Thulin Director |
BUY
Open market or private purchase
|
Direct |
2,832
+49.13%
|
$249,216
$88.25 P/Share
|
|
Feb 06
2025
|
Cristal N Downing Chief Comm. & Public Afrs Ofcr |
SELL
Open market or private sale
|
Direct |
2,361
-24.99%
|
$207,768
$88.76 P/Share
|
|
Feb 05
2025
|
Douglas M Baker Jr Director |
BUY
Open market or private purchase
|
Direct |
15,000
+48.39%
|
$1,320,000
$88.5 P/Share
|
|
Jan 27
2025
|
Dalton Smart SVP Fin. - Global Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,586
+26.94%
|
$250,842
$97.94 P/Share
|
|
Jan 27
2025
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,246
+25.38%
|
$993,862
$97.94 P/Share
|
|
Jan 27
2025
|
Jennifer Zachary EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
25,423
+31.5%
|
$2,466,031
$97.94 P/Share
|
|
Jan 27
2025
|
Caroline Litchfield EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
23,432
+23.97%
|
$2,272,904
$97.94 P/Share
|
|
Jan 27
2025
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Grant, award, or other acquisition
|
Direct |
8,664
+20.99%
|
$840,408
$97.94 P/Share
|
|
Jan 27
2025
|
Cristal N Downing Chief Comm. & Public Afrs Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
9,446
+50.0%
|
$916,262
$97.94 P/Share
|
|
Jan 27
2025
|
Dean Y Li Executive VP & President, MRL |
BUY
Grant, award, or other acquisition
|
Direct |
32,621
+29.07%
|
$3,164,237
$97.94 P/Share
|
|
Jan 27
2025
|
Robert M Davis Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
95,275
+17.68%
|
$9,241,675
$97.94 P/Share
|
|
Jan 27
2025
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Grant, award, or other acquisition
|
Direct |
25,438
+12.44%
|
$2,467,486
$97.94 P/Share
|
|
Jan 27
2025
|
Chirfi Guindo Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,158
+28.94%
|
$2,731,326
$97.94 P/Share
|
|
Jan 27
2025
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Grant, award, or other acquisition
|
Direct |
28,136
+26.32%
|
$2,729,192
$97.94 P/Share
|